Arkolith/Insider Trading/KTTA/Form 4

Steinman Lawrence

DirectorPasithea Therapeutics Corp. (KTTA) · full profile →Form 4 · filed Oct 17, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2022Grant(A)1K$1.14$1K1.3M
Oct 17, 2022Grant(A)9K$1.13$10K1.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-064401) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML